Stay updated with breaking news from Tim Steffensmeier. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PURE Bioscience, Inc. ("PURE," the "Company" or "we"), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal third quarter ended April 30, 2024. Summary of Results ? Fiscal...
July 16th-19th, 2023, Toronto, Ontario, Canada Booth #530
Update on Business Segments and PURE’s SDC-Based Antimicrobial Solutions ... | June 14, 2023
15.12.2021 - PURE Bioscience, Inc. (OTCQB: PURE) (the “Company,” “PURE” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal first quarter ended October 31, 2021. Summary of ...